State & Nation · News & context

OsteoDenx recall flags undeclared milk in two supplement lots

By Staff Writer · Published 11/16/2026, 12:03:53 PM ET

Front of the recalled OsteoDenx 60-capsule carton

OsteoDenx 60-capsule carton in the recall notice. Copied November 16, 2026.

bioQuad Life Sciences, via FDA; image creator unidentified · Official image source · FDA website graphics may be reused unless otherwise noted; no copyright restriction shown on this supplied image.

The updated notice includes additional Amazon carton codes.

bioQuad Life Sciences recalled two OsteoDenx capsule lots November 13 because milk was missing from their labeling. Its updated FDA-posted notice adds two Amazon UPC codes. The company warns that people with milk allergy or severe sensitivity could have a life-threatening reaction.

Check 30- or 60-capsule cartons for lot 0524100, expiring May 2027, or lot 0625041, expiring August 2028. Listed UPCs are 857294007228 and 857294007341; the added Amazon codes are 857294007259 and 857294007242. Lot and expiry appear on the carton side.

Milk-allergic or sensitive consumers should not take affected capsules, the company says. Purchasers may request a full refund or corrected-package replacement. Contact service@bioquad.com or 714-660-1031, weekdays 9:30 a.m.–5 p.m. Pacific.

What it means

Match the lot and expiration date as well as the UPC. The company reports no illnesses and gives no refund filing deadline. FDA is hosting the company’s announcement, which does not constitute product endorsement. A packaging correction is not a milk-free claim.

Source

This State & Nation summary is based on bioQuad Life Sciences announcement published by FDA’s original release, dated 2026-11-13. The reporting above is attributed to the official sources linked here.

Supporting official sources

More release summaries · Editorial standards

Property of State and Nation Media Group LLC.